{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T14:44:48Z","timestamp":1783435488428,"version":"3.54.6"},"reference-count":56,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T00:00:00Z","timestamp":1601337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["01.01.02-10-005\/08 TESTOPLEK"],"award-info":[{"award-number":["01.01.02-10-005\/08 TESTOPLEK"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes"],"abstract":"<jats:p>ATP-binding cassette sub-family G member 2 (ABCG2), also known as breast cancer resistance protein (BCRP), is one of the key efflux ATP-binding cassette (ABC) transporters of xenobiotics, their metabolites and endogenous compounds such as urate. Some of its genetic variants have been found to influence protein functioning, resulting in serious clinical implications concerning chemotherapy response, as well as gout or blood group phenotype Jr(a-). Previous reports have suggested that the frequencies of certain crucial polymorphisms, such as c.34G&gt;A (p.Val12Met) and c.421C&gt;A (p.Gln141Lys) differ significantly between the Polish population and other Caucasian populations. Thus, to clarify this issue, the present study performs a complete analysis of the genetic variation of ABCG2 coding sequence in the Polish population. The genetic variation in 14 out of 15 coding exons of the ABCG2 gene, as well as their flanking intron sequences, were examined among 190 healthy representatives of the Polish population using scanning with High Resolution Melting (HRM). HRM scanning revealed 17 polymorphisms: eight in the exons (including five missense variants and one point-nonsense mutation) and nine in the intron sequences (eight single nucleotide polymorphisms (SNPs) and one deletion variant). These included variants correlating with the presence of gout and phenotype Jr(a-). Linkage disequilibrium, haplotype blocks and haplotype analyses were also performed. The frequencies of the most common polymorphisms in the Polish population did not differ significantly to those observed for other Caucasian populations, but demonstrated divergence from non-Caucasian populations. We hope that our findings may be helpful for other researchers and clinicians, evaluating the pharmacogenetic role of ABCG2.<\/jats:p>","DOI":"10.3390\/genes11101144","type":"journal-article","created":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T08:43:27Z","timestamp":1601369007000},"page":"1144","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Comprehensive Analysis of ABCG2 Genetic Variation in the Polish Population and Its Inter-Population Comparison"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7906-5549","authenticated-orcid":false,"given":"Marcin","family":"S\u0142omka","sequence":"first","affiliation":[{"name":"Biobank Lab, Department of Molecular Biophysics, Faculty of Biology and Environmental Protection, University of \u0141\u00f3d\u017a, Pilarskiego 14\/16, 90-231 \u0141\u00f3d\u017a, Poland"},{"name":"BBMRI.pl Consortium, 54-066 Wroc\u0142aw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Sobalska-Kwapis","sequence":"additional","affiliation":[{"name":"Biobank Lab, Department of Molecular Biophysics, Faculty of Biology and Environmental Protection, University of \u0141\u00f3d\u017a, Pilarskiego 14\/16, 90-231 \u0141\u00f3d\u017a, Poland"},{"name":"BBMRI.pl Consortium, 54-066 Wroc\u0142aw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Korycka-Macha\u0142a","sequence":"additional","affiliation":[{"name":"Institute of Medical Biology, Polish Academy of Sciences, Lodowa 106, 93-232 \u0141\u00f3d\u017a, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1427-884X","authenticated-orcid":false,"given":"Jaros\u0142aw","family":"Dziadek","sequence":"additional","affiliation":[{"name":"Institute of Medical Biology, Polish Academy of Sciences, Lodowa 106, 93-232 \u0141\u00f3d\u017a, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0347-0740","authenticated-orcid":false,"given":"Grzegorz","family":"Bartosz","sequence":"additional","affiliation":[{"name":"Department of Molecular Biophysics, Faculty of Biology and Environmental Protection, University of \u0141\u00f3d\u017a, Pomorska 141\/143, 90-236 \u0141\u00f3d\u017a, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9752-4270","authenticated-orcid":false,"given":"Dominik","family":"Strapagiel","sequence":"additional","affiliation":[{"name":"Biobank Lab, Department of Molecular Biophysics, Faculty of Biology and Environmental Protection, University of \u0141\u00f3d\u017a, Pilarskiego 14\/16, 90-231 \u0141\u00f3d\u017a, Poland"},{"name":"BBMRI.pl Consortium, 54-066 Wroc\u0142aw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,9,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2008.11.003","article-title":"ABCG2: A perspective","volume":"61","author":"Robey","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"15665","DOI":"10.1073\/pnas.95.26.15665","article-title":"A multidrug resistance transporter from human MCF-7 breast cancer cells","volume":"95","author":"Doyle","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_3","first-page":"5337","article-title":"A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance","volume":"58","author":"Allikmets","year":"1998","journal-title":"Cancer Res."},{"key":"ref_4","first-page":"4237","article-title":"The mouse Bcrp1\/Mxr\/Abcp gene: Amplification and overexpression in cell lines selected for resistance to topotecan, mitoxantrone, or doxorubicin","volume":"59","author":"Allen","year":"1999","journal-title":"Cancer Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1124\/mol.113.088609","article-title":"Molecular pharmacology of ABCG2 and its role in chemoresistance","volume":"84","author":"Stacy","year":"2013","journal-title":"Mol. Pharmacol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.addr.2008.07.003","article-title":"Functions of the breast cancer resistance protein (BCRP\/ABCG2) in chemotherapy","volume":"61","author":"Noguchi","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"7340","DOI":"10.1038\/sj.onc.1206938","article-title":"Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2)","volume":"22","author":"Doyle","year":"2003","journal-title":"Oncogene"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"595","DOI":"10.2174\/138920111795163913","article-title":"The challenge of exploiting ABCG2 in the clinic","volume":"12","author":"Robey","year":"2011","journal-title":"Curr. Pharm. Biotechnol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s10555-007-9042-6","article-title":"ABCG2: Determining its relevance in clinical drug resistance","volume":"26","author":"Robey","year":"2007","journal-title":"Cancer Metastasis Rev."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.bcp.2012.01.002","article-title":"Role of breast cancer resistance protein (BCRP\/ABCG2) in cancer drug resistance","volume":"83","author":"Natarajan","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.freeradbiomed.2014.07.020","article-title":"Collateral sensitivity: ABCG2-overexpressing cells are more vulnerable to oxidative stress","volume":"76","author":"Bartosz","year":"2014","journal-title":"Free Radic. Biol. Med."},{"key":"ref_12","first-page":"5","article-title":"Human ABC transporter ABCG2 in cancer chemotherapy and pharmacogenomics","volume":"8","author":"Ishikawa","year":"2009","journal-title":"J. Exp. Ther. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"10338","DOI":"10.1073\/pnas.0901249106","article-title":"Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout","volume":"106","author":"Woodward","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1080\/03602530801952617","article-title":"Pharmacogenomics of MRP transporters (ABCC1-5) and BCRP (ABCG2)","volume":"40","author":"Gradhand","year":"2008","journal-title":"Drug Metab. Rev."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1007\/s00204-014-1224-8","article-title":"Structure and function of BCRP, a broad specificity transporter of xenobiotics and endobiotics","volume":"88","author":"Jani","year":"2014","journal-title":"Arch. Toxicol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/ng.1070","article-title":"Null alleles of ABCG2 encoding the breast cancer resistance protein define the new blood group system Junior","volume":"44","author":"Saison","year":"2012","journal-title":"Nat. Genet."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/ng.1075","article-title":"ABCG2 null alleles define the Jr(a-) blood group phenotype","volume":"44","author":"Zelinski","year":"2012","journal-title":"Nat. Genet."},{"key":"ref_18","first-page":"129","article-title":"ABCG2 polymorphisms in gout: Insights into disease susceptibility and treatment approaches","volume":"10","author":"Cleophas","year":"2017","journal-title":"Pharmgenom. Pers. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.canlet.2005.01.061","article-title":"The role of the human ABCG2 multidrug transporter and its variants in cancer therapy and toxicology","volume":"234","author":"Cervenak","year":"2006","journal-title":"Cancer Lett."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"5889","DOI":"10.1158\/1078-0432.CCR-04-0144","article-title":"ABCG2 pharmacogenetics: Ethnic differences in allele frequency and assessment of influence on irinotecan disposition","volume":"10","author":"Marsh","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2133\/dmpk.DMPK-11-RV-111","article-title":"Population differences in major functional polymorphisms of pharmacokinetics\/pharmacodynamics-related genes in Eastern Asians and Europeans: Implications in the clinical trials for novel drug development","volume":"27","author":"Kurose","year":"2012","journal-title":"Drug Metab. Pharmacokinet."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2133\/dmpk.DMPK-11-RV-098","article-title":"Functional significance of genetic polymorphisms in P-glycoprotein (MDR1, ABCB1) and breast cancer resistance protein (BCRP, ABCG2)","volume":"27","author":"Ieiri","year":"2012","journal-title":"Drug Metab. Pharmacokinet."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.bbrc.2018.06.157","article-title":"Polymorphisms of ABCG2 and its impact on clinical relevance","volume":"503","author":"Zhang","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1046\/j.1529-8817.2003.00124.x","article-title":"Linkage disequilibrium and haplotype architecture for two ABC transporter genes (ABCC1 and ABCG2) in Chinese population: Implications for pharmacogenomic association studies","volume":"68","author":"Wang","year":"2004","journal-title":"Ann. Hum. Genet."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1124\/dmd.106.012302","article-title":"Identification and functional assessment of BCRP polymorphisms in a Korean population","volume":"35","author":"Lee","year":"2007","journal-title":"Drug Metab. Dispos."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2133\/dmpk.21.109","article-title":"Genetic variation and haplotype structure of the ABC transporter gene ABCG2 in a Japanese population","volume":"21","author":"Maekawa","year":"2006","journal-title":"Drug Metab. Pharmacokinet."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0928-0987(03)00038-1","article-title":"Genetic variation in the ATP-binding cassette transporter gene ABCG2 (BCRP) in a Swedish population","volume":"18","author":"Backstrom","year":"2003","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_28","first-page":"123","article-title":"Detection of single nucleotide polymorphisms in the ABCG2 gene in a Dutch population","volume":"5","author":"Bosch","year":"2005","journal-title":"Am. J. Pharm."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s13353-015-0327-0","article-title":"ABCG2 in peptic ulcer: Gene expression and mutation analysis","volume":"57","author":"Zebrowska","year":"2016","journal-title":"J. Appl. Genet."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.2147\/OTT.S195245","article-title":"The contribution of ABCG2 G34A and C421A polymorphisms to multiple myeloma susceptibility","volume":"12","author":"Niebudek","year":"2019","journal-title":"Onco. Targets Ther."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.5334\/ojb.22","article-title":"Biobank Lodz-DNA Based Biobank at the University of Lodz, Poland","volume":"3","author":"Strapagiel","year":"2016","journal-title":"Open J. Bioresour."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"85","DOI":"10.31373\/ejtcm\/109495","article-title":"Biobank \u0141\u00f3d\u017a-population based biobank at the University of \u0141\u00f3d\u017a, Poland","volume":"2","author":"Dobrowolska","year":"2019","journal-title":"Eur. J. Transl. Clin. Med."},{"key":"ref_33","unstructured":"Strapagiel, D., Majewska, M., S\u0142omka, M., Janik, K., Sobalska, M., and Bartosz, G. (2019). Method for Determination of Gender. (Number: PL 232652 B1), Patent."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"S\u0142omka, M., Sobalska-Kwapis, M., Korycka-Machala, M., Bartosz, G., Dziadek, J., and Strapagiel, D. (2015). Genetic variation of the ABC transporter gene ABCC1 (Multidrug resistance protein 1-MRP1) in the Polish population. BMC Genet., 16.","DOI":"10.1186\/s12863-015-0271-3"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"S\u0142omka, M., Sobalska-Kwapis, M., Wachulec, M., Bartosz, G., and Strapagiel, D. (2017). High Resolution Melting (HRM) for High-Throughput Genotyping-Limitations and Caveats in Practical Case Studies. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18112316"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1086\/344398","article-title":"Distribution of recombination crossovers and the origin of haplotype blocks: The interplay of population history, recombination, and mutation","volume":"71","author":"Wang","year":"2002","journal-title":"Am. J. Hum. Genet."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1080\/00365520601101559","article-title":"ATP-binding cassette transporter ABCG2 (BCRP) and ABCB1 (MDR1) variants are not associated with disease susceptibility, disease phenotype response to medical therapy or need for surgeryin Hungarian patients with inflammatory bowel diseases","volume":"42","author":"Fischer","year":"2007","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1093\/rheumatology\/kex295","article-title":"Functional non-synonymous variants of ABCG2 and gout risk","volume":"56","author":"Stiburkova","year":"2017","journal-title":"Rheumatology"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1002\/ijc.23956","article-title":"Polymorphisms in ABCG2, ABCC3 and CNT1 genes and their possible impact on chemotherapy outcome of lung cancer patients","volume":"124","author":"Muller","year":"2009","journal-title":"Int. J. Cancer"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Stark, K., Reinhard, W., Grassl, M., Erdmann, J., Schunkert, H., Illig, T., and Hengstenberg, C. (2009). Common polymorphisms influencing serum uric acid levels contribute to susceptibility to gout, but not to coronary artery disease. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0007729"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"9149","DOI":"10.3390\/ijms15059149","article-title":"Functional polymorphisms of the ABCG2 gene are associated with gout disease in the Chinese Han male population","volume":"15","author":"Zhou","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/trf.12277","article-title":"Defining the Jr(a-) phenotype in the Japanese population","volume":"54","author":"Tanaka","year":"2014","journal-title":"Transfusion"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00018-019-03186-2","article-title":"Cellular expression and function of naturally occurring variants of the human ABCG2 multidrug transporter","volume":"77","author":"Bartos","year":"2020","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.bcp.2017.10.004","article-title":"BCRP\/ABCG2 and high-alert medications: Biochemical, pharmacokinetic, pharmacogenetic, and clinical implications","volume":"147","author":"Hira","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/jhg.2010.98","article-title":"Influence of CYP3A5 and drug transporter polymorphisms on imatinib trough concentration and clinical response among patients with chronic phase chronic myeloid leukemia","volume":"55","author":"Takahashi","year":"2010","journal-title":"J. Hum. Genet"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1159\/000324900","article-title":"Therapeutic drug monitoring of imatinib for chronic myeloid leukemia patients in the chronic phase","volume":"87","author":"Takahashi","year":"2011","journal-title":"Pharmacology"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"7102","DOI":"10.1158\/1078-0432.CCR-08-0950","article-title":"Population pharmacokinetics and pharmacogenetics of imatinib in children and adults","volume":"14","author":"Petain","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"7901","DOI":"10.1007\/s13277-015-4679-1","article-title":"Association of ABCB1 and ABCG2 single nucleotide polymorphisms with clinical findings and response to chemotherapy treatments in Kurdish patients with breast cancer","volume":"37","author":"Ghafouri","year":"2016","journal-title":"Tumour. Biol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"279109","DOI":"10.1155\/2015\/279109","article-title":"Genetic Variations in ABCG2 Gene Predict Breast Carcinoma Susceptibility and Clinical Outcomes after Treatment with Anthracycline-Based Chemotherapy","volume":"2015","author":"Wu","year":"2015","journal-title":"BioMed Res. Int."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1080\/0284186X.2016.1265666","article-title":"Assessment of ethnic differences in sunitinib outcome between Caucasian and Asian patients with metastatic renal cell carcinoma: A meta-analysis","volume":"56","author":"Liu","year":"2017","journal-title":"Acta Oncol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1038\/s41598-018-21425-7","article-title":"ABCG2 contributes to the development of gout and hyperuricemia in a genome-wide association study","volume":"8","author":"Chen","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/aje\/kws330","article-title":"Association of functional polymorphism rs2231142 (Q141K) in the ABCG2 gene with serum uric acid and gout in 4 US populations: The PAGE Study","volume":"177","author":"Zhang","year":"2013","journal-title":"Am. J. Epidemiol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1093\/rheumatology\/keq096","article-title":"The rs2231142 variant of the ABCG2 gene is associated with uric acid levels and gout among Japanese people","volume":"49","author":"Yamagishi","year":"2010","journal-title":"Rheumatology"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"9988","DOI":"10.1038\/s41598-017-10196-2","article-title":"A comprehensive analysis of the association of common variants of ABCG2 with gout","volume":"7","author":"Yu","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Toyoda, Y., Man\u010d\u00edkov\u00e1, A., Krylov, V., Morimoto, K., Pavelcov\u00e1, K., Bohat\u00e1, J., Pavelka, K., Pavl\u00edkov\u00e1, M., Suzuki, H., and Matsuo, H. (2019). Functional Characterization of Clinically-Relevant Rare Variants in ABCG2 Identified in a Gout and Hyperuricemia Cohort. Cells, 8.","DOI":"10.3390\/cells8040363"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1111\/trf.12544","article-title":"Molecular analysis of immunized Jr(a-) or Lan- patients and validation of a high-throughput genotyping assay to screen blood donors for Jr(a-) and Lan- phenotypes","volume":"54","author":"Ligthart","year":"2014","journal-title":"Transfusion"}],"container-title":["Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4425\/11\/10\/1144\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:14:41Z","timestamp":1760177681000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4425\/11\/10\/1144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,29]]},"references-count":56,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,10]]}},"alternative-id":["genes11101144"],"URL":"https:\/\/doi.org\/10.3390\/genes11101144","relation":{},"ISSN":["2073-4425"],"issn-type":[{"value":"2073-4425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,29]]}}}